A literature review on pharmacologic therapy for abdominal aortic aneurysms
MR Rodrigues, RG e Melo, L Silvestre… - Angiologia e Cirurgia …, 2023 - acvjournal.com
Abstract Aortic aneurysms affect 3.3% of adults and there is a growing burden of small
aneurysms detected, which may grow to need surgical repair. Still, we rely only on surgical …
aneurysms detected, which may grow to need surgical repair. Still, we rely only on surgical …
Cellular Mechanism of Pentagalloyl Gucose-Mediated Prevention and Reversal of Abdominal Aortic Aneurysms
G Halsey - 2023 - search.proquest.com
Abdominal aortic aneurysm (AAA) has been the 15th leading cause of death in persons
older than 55 for the past ten years in several Western countries, with rupture resulting in an …
older than 55 for the past ten years in several Western countries, with rupture resulting in an …
Captopril versus atenolol to prevent expansion rate of thoracic aortic aneurysms: rationale and design
M Spartalis, E Tzatzaki, DC Iliopoulos… - Future …, 2021 - Taylor & Francis
Thoracic aortic aneurysms are correlated with significant mortality and morbidity. No therapy,
however, is effective at limiting aneurysm expansion and preventing rupture. Angiotensin …
however, is effective at limiting aneurysm expansion and preventing rupture. Angiotensin …
Utilising novel clinically relevant mouse models to test new therapeutic interventions for peripheral artery diseases
JA Phie - 2020 - researchonline.jcu.edu.au
James Phie researched and developed new patient relevant laboratory models and tested
interventions for diseases in the blood vessels. These findings pave the way for the …
interventions for diseases in the blood vessels. These findings pave the way for the …
[PDF][PDF] Cellular signalling in abdominal aortic aneurysms: Towards better prediction of aneurysm progression and rupture
ME Groeneveld - 2020 - research.vu.nl
Objective: The pathophysiology of aortic aneurysms (AA) remains unclear. AA is an
unpredictable disease, which often results in rupture, causing bleeding and death. Currently …
unpredictable disease, which often results in rupture, causing bleeding and death. Currently …
Investigation into the in vivo and in vitro effects of anti-angiogenic therapy on abdominal aortic aneurysms
B Vijaynagar - 2020 - figshare.le.ac.uk
Medical therapy to prevent abdominal aortic aneurysm (AAA) development and progression
is not currently available. Angiogenesis and extracellular signal-related kinase (ERK) …
is not currently available. Angiogenesis and extracellular signal-related kinase (ERK) …
The role of vitamin D in the development and progression of experimental abdominal aortic aneurysm
V Nsengiyumva - 2019 - researchonline.jcu.edu.au
Vianne Nsengiyumva conducted experimental investigations into the role of vitamin D on
abdominal aortic aneurysms (AAA). Vitamin D supplementation to achieve optimal …
abdominal aortic aneurysms (AAA). Vitamin D supplementation to achieve optimal …
The Year in Vascular Anesthesia: Selected Highlights From 2018
EA Valentine, EY Zhou, AK Gold, EA Ochroch - Journal of Cardiothoracic …, 2019 - Elsevier
This special article is the second in an annual series for the Journal of Cardiothoracic and
Vascular Anesthesia that is specifically dedicated to highlights in vascular anesthesiology …
Vascular Anesthesia that is specifically dedicated to highlights in vascular anesthesiology …
[PDF][PDF] Versorgungsrealität der optimalen medikamentösen Versorgung bei Patienten mit infrarenalem Aortenaneurysma
J Hansmann - 2016 - oparu.uni-ulm.de
Patienten mit abdominellemAortenaneurysma (AAA) gelten als kardiovaskuläre
Risikopatienten. Das AAA ist mit hohen Morbiditäts-und Mortalitätsraten verbunden …
Risikopatienten. Das AAA ist mit hohen Morbiditäts-und Mortalitätsraten verbunden …